Genelux Corporation Profile Avatar - Palmy Investing

Genelux Corporation

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-…

Biotechnology
US, Westlake Village [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Genelux Corporation (GNLX) to it's peer group.

Peer Group
Loading...
End of GNLX's Analysis
CIK: 1231457 CUSIP: - ISIN: US36870H1032 LEI: - UEI: -
Secondary Listings
GNLX has no secondary listings inside our databases.